Bo Hu

机构：Xuzhou Medical College, The First People’s Hospital of Lianyungang · ORCID：0000-0003-2213-7385

发表论文 171 篇 · 总被引 3588 次 · h-index 23

代表论文

• Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma (2024 · ACS Nano · 被引 57)
• Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy (2024 · Biomaterials · 被引 56)
• Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA (2024 · Nature Communications · 被引 42)
• Spatiotemporal‐Controlled NIR‐II Immune Agonist Sensitizes Cancer Immunotherapy (2024 · Advanced Materials · 被引 29)
• A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer (2024 · Journal of Medicinal Chemistry · 被引 20)
• Oral ruthenium-based PAD4 inhibitor modulates immunogenic cell death and neutrophil extracellular traps in triple-negative breast cancer (2025 · Journal of Controlled Release · 被引 9)